Ledger.Open graph →
SEC Form D · filed April 2, 2015

Immune Therapeutics, Inc

Offering
—
Sold
$200K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ORLANDO, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Seth Elliott · Murfreesboro, TNExecEugene Youkilis · BETHESDA, MDDirectorChristopher Pearce · BETHESDA, MDDirectorEdward Teraskiewicz · Orlando, FLDirectorNoreen Griffin · BETHESDA, MDExec · DirectorAngus Dalgleish · Orlando, FLExecVincent Butta · Orlando, FLDirectorNicholas Plotnikoff · Orlando, FLDirectorPeter Aronstam · BETHESDA, MDExecFengping Shan · Orlando, FLExecJoseph Fortunak · Orlando, FLExecChristopher Pearce · Orlando, FLDirectorEdward Teraskiewicz · Orlando, FLDirectorNoreen Griffin · Orlando, FLExec · DirectorAngus Dalgleish · Orlando, FLExecVincent Butta · Orlando, FLDirectorSeth Elliott · Orlando, FLExecEugene Youkilis · Orlando, FLDirectorNicholas Plotnikoff · Orlando, FLDirectorPeter Aronstam · Orlando, FLExecFengping Shan · Orlando, FLExecJoseph Fortunak · Orlando, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗